Literature DB >> 31527031

Coinfections of Two Strains of NDM-1- and OXA-232-Coproducing Klebsiella pneumoniae in a Kidney Transplant Patient.

Deisy A Contreras1, Sean P Fitzwater2, Deepa D Nanayakkara3, Joanna Schaenman3, Grace M Aldrovandi2, Omai B Garner1, Shangxin Yang4.   

Abstract

We report here a fatal case of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in a renal transplant patient without a travel history in the prior year, from whom 2 genetically different CRKP (sequence type 14 [ST14] and ST2497) strains carrying the same plasmids and antimicrobial resistance genes, including bla NDM-1, bla OXA-232, bla CTX-M-15, armA, and tet(D), were isolated from blood and the abdominal cavity. The isolates were susceptible to colistin, tigecycline, eravacycline, and cefiderocol, which was used to treat the CRKP in combination with ceftazidime-avibactam and polymyxin B and resulted in bacterial clearance. Despite the aggressive treatment, the patient died of ischemic colitis and multiorgan failure.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  CRKP; NDM-1; OXA-232; ST14; ST2497; carbapenem resistance; carbapenemase coproduction; cefiderocol

Mesh:

Substances:

Year:  2020        PMID: 31527031      PMCID: PMC7179284          DOI: 10.1128/AAC.00948-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  Cefiderocol: a novel siderophore cephalosporin.

Authors:  Justin J Choi; Matthew W McCarthy
Journal:  Expert Opin Investig Drugs       Date:  2018-01-24       Impact factor: 6.206

2.  Genomic Characterization of Carbapenemase-Producing Klebsiella pneumoniae with Chromosomally Carried bla NDM-1.

Authors:  Noriko Sakamoto; Yukihiro Akeda; Yo Sugawara; Dan Takeuchi; Daisuke Motooka; Norihisa Yamamoto; Warawut Laolerd; Pitak Santanirand; Shigeyuki Hamada
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

3.  Emergence of Klebsiella pneumoniae co-producing NDM-type and OXA-181 carbapenemases.

Authors:  M N D Balm; M-V La; P Krishnan; R Jureen; R T P Lin; J W P Teo
Journal:  Clin Microbiol Infect       Date:  2013-05-13       Impact factor: 8.067

4.  Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates.

Authors:  Carole Ayoub Moubareck; Shaimaa F Mouftah; Tibor Pál; Akela Ghazawi; Dalal H Halat; Anju Nabi; Mouza A AlSharhan; Zulfa O AlDeesi; Christabel C Peters; Handan Celiloglu; Manjunath Sannegowda; Dolla K Sarkis; Ágnes Sonnevend
Journal:  Int J Antimicrob Agents       Date:  2018-03-09       Impact factor: 5.283

5.  In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).

Authors:  Yunliang Zhang; Ankita Kashikar; Karen Bush
Journal:  J Antimicrob Chemother       Date:  2017-10-01       Impact factor: 5.790

Review 6.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  Whole-genome assembly of Klebsiella pneumoniae coproducing NDM-1 and OXA-232 carbapenemases using single-molecule, real-time sequencing.

Authors:  Yohei Doi; Tracy H Hazen; Matthew Boitano; Yu-Chih Tsai; Tyson A Clark; Jonas Korlach; David A Rasko
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

8.  Evolution and Transmission of Carbapenem-Resistant Klebsiella pneumoniae Expressing the blaOXA-232 Gene During an Institutional Outbreak Associated With Endoscopic Retrograde Cholangiopancreatography.

Authors:  Shangxin Yang; Peera Hemarajata; Janet Hindler; Fan Li; Helty Adisetiyo; Grace Aldrovandi; Robert Sebra; Andrew Kasarskis; Duncan MacCannell; Xavier Didelot; Dana Russell; Zachary Rubin; Romney Humphries
Journal:  Clin Infect Dis       Date:  2017-04-01       Impact factor: 9.079

9.  Novel autoproteolytic and DNA-damage sensing components in the bacterial SOS response and oxidized methylcytosine-induced eukaryotic DNA demethylation systems.

Authors:  L Aravind; Swadha Anand; Lakshminarayan M Iyer
Journal:  Biol Direct       Date:  2013-08-15       Impact factor: 4.540

10.  Complete Genome Sequence of Klebsiella pneumoniae subsp. pneumoniae KP617, Coproducing OXA-232 and NDM-1 Carbapenemases, Isolated in South Korea.

Authors:  Taesoo Kwon; Ji Woo Yang; Sanghyun Lee; Mi-Ran Yun; Won Gi Yoo; Hwa Su Kim; Jeong-Ok Cha; Dae-Won Kim
Journal:  Genome Announc       Date:  2016-01-14
View more
  13 in total

1.  Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data?

Authors:  Ryan K Shields
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

Review 2.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

Review 3.  New Perspectives on Antimicrobial Agents: Cefiderocol.

Authors:  Erin K McCreary; Emily L Heil; Pranita D Tamma
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

4.  Detection and Characterization of Targeted Carbapenem-Resistant Health Care-Associated Threats: Findings from the Antibiotic Resistance Laboratory Network, 2017 to 2019.

Authors:  Sarah Sabour; Jennifer Y Huang; Amelia Bhatnagar; Sarah E Gilbert; Maria Karlsson; David Lonsway; Joseph D Lutgring; J Kamile Rasheed; Alison Laufer Halpin; Richard A Stanton; Stephanie Gumbis; Christopher A Elkins; Allison C Brown
Journal:  Antimicrob Agents Chemother       Date:  2021-09-27       Impact factor: 5.191

5.  VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa.

Authors:  Jodie C Hamrick; Jean-Denis Docquier; Tsuyoshi Uehara; Cullen L Myers; David A Six; Cassandra L Chatwin; Kaitlyn J John; Salvador F Vernacchio; Susan M Cusick; Robert E L Trout; Cecilia Pozzi; Filomena De Luca; Manuela Benvenuti; Stefano Mangani; Bin Liu; Randy W Jackson; Greg Moeck; Luigi Xerri; Christopher J Burns; Daniel C Pevear; Denis M Daigle
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 6.  Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales.

Authors:  Xing Tan; Hwan Seung Kim; Kimberly Baugh; Yanqin Huang; Neeraja Kadiyala; Marisol Wences; Nidhi Singh; Eric Wenzler; Zackery P Bulman
Journal:  Infect Drug Resist       Date:  2021-01-18       Impact factor: 4.003

7.  Genetic Plurality of OXA/NDM-Encoding Features Characterized From Enterobacterales Recovered From Czech Hospitals.

Authors:  Katerina Chudejova; Lucie Kraftova; Vittoria Mattioni Marchetti; Jaroslav Hrabak; Costas C Papagiannitsis; Ibrahim Bitar
Journal:  Front Microbiol       Date:  2021-02-09       Impact factor: 5.640

Review 8.  Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data.

Authors:  Daniele Roberto Giacobbe; Eugenio Ciacco; Corrado Girmenia; Federico Pea; Gian Maria Rossolini; Giovanni Sotgiu; Carlo Tascini; Mario Tumbarello; Pierluigi Viale; Matteo Bassetti
Journal:  Infect Drug Resist       Date:  2020-12-29       Impact factor: 4.003

9.  Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives.

Authors:  Davide Fiore Bavaro; Alessandra Belati; Lucia Diella; Monica Stufano; Federica Romanelli; Luca Scalone; Stefania Stolfa; Luigi Ronga; Leonarda Maurmo; Maria Dell'Aera; Adriana Mosca; Lidia Dalfino; Salvatore Grasso; Annalisa Saracino
Journal:  Antibiotics (Basel)       Date:  2021-05-29

10.  Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature.

Authors:  Sandra Zingg; G Jacopo Nicoletti; Sabine Kuster; Milena Junker; Andreas Widmer; Adrian Egli; Vladimira Hinic; Parham Sendi; Manuel Battegay; Veronika Bättig; Nina Khanna; Sarah Tschudin-Sutter
Journal:  Open Forum Infect Dis       Date:  2020-05-21       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.